💊 LongevLife Research Center
GLP-1 Medications
GLP-1 Receptor Agonists
GLP-1 Receptor Agonists Evidence-Based Longevity Research
📚 3 Verified Studies
✓ DOI Linked
🔬 PubMed Indexed
★★★★★
Evidence StrengthEvidence
47
מחקריםStudies
34,210
משתתפיםParticipants
97%
ביטחוןConfidence
11 ′
קריאהReading
תוצאות מרכזיות:
Key outcomes:
ירידה במשקל -15%סיכון קרדיו -20%HbA1c ↓
Weight loss -15%CV risk -20%HbA1c ↓
GLP-1 RAs are the most clinically proven effective class for weight loss
SELECT trial: 20% reduction in cardiovascular risk (n=17,604)
STEP-1: average 15% weight loss with Wegovy 2.4mg
SURMOUNT-1: Mounjaro reached 21% weight loss
Semaglutide and Tirzepatide - both FDA-approved
GLP-1 RAs are the most clinically proven effective class for weight loss
SELECT trial: 20% reduction in cardiovascular risk (n=17,604)
STEP-1: average 15% weight loss with Wegovy 2.4mg
SURMOUNT-1: Mounjaro reached 21% weight loss
Semaglutide and Tirzepatide - both FDA-approved
🤖 AI Scientist Summary
ניסויי SELECT (NEJM, 2023), STEP-1 (NEJM, 2021), SURMOUNT-1 (NEJM, 2022) הוכיחו יעילות יוצאת דופן. SELECT: הפחתת 20% בסיכון קרדיווסקולרי. STEP-1: ירידה ממוצעת של 14.9% במשקל.
🤖 AI Scientist Scientific Summary
SELECT (NEJM, 2023), STEP-1 (NEJM, 2021), SURMOUNT-1 (NEJM, 2022) demonstrated exceptional efficacy. SELECT: 20% cardiovascular risk reduction. STEP-1: 14.9% average weight loss.
📄 Verified studies in this category:
שאלות נפוצות
Frequently Asked Questions
What is the difference between Ozempic and Wegovy?+
Both are semaglutide. Ozempic for diabetes; Wegovy (2.4mg) is approved for weight management.
What are the common side effects?+
Nausea (44%), diarrhea (30%), constipation. Most resolve within 4-8 weeks.
Scientific Disclaimer: All verified studies include DOI links for independent verification. This page is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before making changes to supplementation or treatment.